MPhil呼吸内科

我们在阻塞性肺疾病（哮喘/ COPD），纤维化肺疾病（IPF，LAM）和感染性肺疾病（囊性纤维化，肺炎）方面有研究计划。我们的研究重点是遗传学，药物遗传学，分子病理生理学，转化研究（包括生物标志物和影像学）和临床试验。在呼吸主题方面，我们与诺丁汉其他研究组中的研究人员（例如流行病学，分子微生物学，药物发现，过敏，免疫学和儿童健康）有着密切的联系。我们是与主要学术机构和行业紧密合作的几个重大国家/国际合作的一部分（例如MRCMAP COPD，NIHR TRP在炎症性疾病和UBIOPRED IMI联盟）。我们
We have research programmes in obstructive lung diseases (Asthma/COPD), fibrotic lung diseases (IPF, LAM) and infective lung diseases (cystic fibrosis, pneumonia). Our research focuses on genetics, pharmacogenetics, molecular pathophysiology, translational research (including biomarkers and imaging) and clinical trials. We have close links on respiratory themes with researchers within other research groupings in Nottingham such as epidemiology, molecular microbiology, drug discovery, allergy, immunology and child health. We are part of several major national/international collaborations (eg MRCMAP COPD, NIHR TRP in inflammatory diseases and UBIOPRED IMI consortia) working closely with major academic institutions and industry. We host the National Centre for research into lymphangiolyomyomatosis (LAM).